Page 273 - ACCCN's Critical Care Nursing

250 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

81. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA et al. Effect of carvedilol textbook of cardiovascular medicine, 7th edn. Philadelphia: Elsevier Saunders;
on the morbidity of patients with severe chronic heart failure: results of the 2008. p. 807
carvedilol prospective randomized cumulative survival (COPERNICUS) 94. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356(9227):
study. Circulation 2002; 106: 2194–9. 411–17.
82. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P et al. Effects of 95. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in preg-
candesartan in patients with chronic heart failure and reduced left-ventricular nancy. Crit Care Med 2005; 33(Suppl 10): S307–12.
systolic function taking angiotensin converting-enzyme inhibitors: the 96. Shapiro S. Cardiac problems in critical care. In Bongard FS, Sue DY, eds.
CHARM-Added trial. Lancet 2003; 362(9386): 767–71. Current critical care: diagnosis and treatment, 2nd edn. New York: Lange Medical
83. Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A Books/McGraw-Hill; 2002.
randomized trial of the angiotensin receptor blocker valsartan in chronic 97. Baas LS. Hypertensive emergencies. In: Baird MS, Keen JH, Swearingen PL,
heart failure. N Engl J Med 2001; 345(23): 1667–75. eds. Manual of critical care nursing: nursing interventions and collaborative man-
84. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A et al. The effect of spi- agement, 5th edition. St Louis: Elsevier Mosby; 2005
ronolactone on morbidity and mortality in patients with severe heart failure. 98. Karchmer AW. Infective endocarditis. In: Zipes DP, Libby P, Bonow RO,
Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; Braunwald E, editors. Braunwald’s heart disease: a textbook of cardiovascular
341: 709–17. medicine, 7th edn. Philadelphia: Elsevier Saunders; 2008. p. 1077
85. Pitt B, Remme W, Zannad F, Neaton J, Martinez F et al. Eplerenone, a selective 99. Baas LS. Acute infective endocarditis. In: Baird MS, Keen JH, Swearingen
aldosterone blocker, in patients with left ventricular dysfunction after myo- PL, eds. Manual of critical care nursing: nursing interventions and collaborative
cardial infarction. N Engl J Med 2003; 348:1309–21. management, 5th edn. St Louis: Elsevier Mosby; 2005.
86. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term 100. Crawford MH, Durack DT. Clinical presentation of infective endocarditis.
comparison of the implantable cardioverter defibrillator versus amiodarone: Cardiol Clin 2003; 21: 159–66.
eleven-year follow-up of a subset of patients in the Canadian Implantable 101. Bashore T, Cabell CH, Fowler V. Update on infective endocarditis. Current
Defibrillator Study (CIDS). Circulation 2004; 110: 112–16. Prob Cardio 2006; 31: 274–352.
87. Moser D, Mann D. Improving outcomes in heart failure: it’s not unusual 102. Isselbacher EM, Eagle KA, Descanctis RW. Diseases of the aorta. In: Zipes
beyond usual care (Editorial). Circulation 2002; 105: 2810–12. DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s heart disease: a text-
88. Wynne JA, Braunwald E. The cardiomyopathies and myocarditides. In: Zipes book of cardiovascular medicine, 7th edn. Philadelphia: Elsevier Saunders;
DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s heart disease: a text- 2008. p. 1546
book of cardiovascular medicine, 7th edn. Philadelphia: Elsevier Saunders; 103. Antman EM. ST-Elevation myocardial infarction: Management. In: Zipes
2008. p. 1404. DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s heart disease: a textbook
89. Deedwania PC. The key to unravelling the mystery of mortality in heart of cardiovascular medicine, 7th edn. Philadelphia: Elsevier Saunders; 2008. p.
failure: An integrated approach. Circulation 2003; 107:1719. 1215
90. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS et al. ACC/AHA 104. Bryant B, Knights K, Saterno E. Pharmacology for Health Professionals. Sydney:
2005 Guideline Update for the Diagnosis and Management of Chronic Heart Mosby; 2003.
Failure in the Adult: a report of the American College of Cardiology/American 105. Bersten AD, Soni N, Oh TE. Oh’s intensive care manual, 5th edn. Oxford:
Heart Association Task Force on Practice Guidelines (Writing Committee to Butterworth-Heinemann, 2003.
Update the 2001 Guidelines for the Evaluation and Management of Heart 106. Urden L, Stacy K, Logh M. Thelan’s critical care nursing: diagnosis and manage-
Failure): developed in collaboration with the American College of Chest ment, 5th edn. St Louis: Mosby; 2006.
Physicians and the International Society for Heart and Lung Transplantation: 107. Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic
endorsed by the Heart Rhythm Society. Circulation 2005;112:e154–235. review of multidisciplinary interventions in heart failure. Heart 2005; 91(7):
91. Finkelmeier BA. Cardiomyopathies. In: Finkelmeier BA. Cardiothoracic surgical 899–906.
nursing, 2nd edn. Philadelphia: , Williams & Wilkins; 2000. p. 59. 108. Davies MK, Gibbs CR, Lip GYH. ABC of heart failure. Management: diuretics,
92. Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L et al. Hyper- ACE inhibitors, and nitrates. BMJ 2000; 320(7232): 428–31.
trophic obstructive cardiomyopathy: comparison of outcomes after myec- 109. Michaelson CR. Congestive heart failure. St Louis: Mosby; 1983.
tomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc 110. Hudak CM, Gallo BM, Morton PG. Critical care nursing: A holistic approach,
Surg 2005; 129(2): 351–8. 7th edn. Philadelphia: Lippincott & Williams; 1998.
93. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. In: Zipes
DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s heart disease: a